NeuBase Therapeutics, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
8.50
|
|
Average Rating
|
3.33
|
|
# Strong Buys
|
0
|
|
# Buys
|
1
|
|
# Holds
|
2
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.28
|
-0.24
|
0.04
|
14.29%
|
|
2022-06-30
|
-0.30
|
-0.26
|
0.04
|
13.33%
|
|
2022-03-31
|
-0.23
|
-0.30
|
-0.07
|
-30.43%
|
|
2021-12-31
|
-0.23
|
-0.24
|
-0.01
|
-4.35%
|
|
2021-09-30
|
-0.23
|
-0.21
|
0.02
|
8.70%
|
|
2021-06-30
|
-0.21
|
-0.29
|
-0.08
|
-38.10%
|
|
2021-03-31
|
-0.22
|
-0.24
|
-0.02
|
-9.09%
|
|
2020-12-31
|
-0.23
|
-0.18
|
0.05
|
21.74%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
0.00
|
|
2022-09-30
|
-1.04
|
|
2021-09-30
|
-0.92
|
|
2020-09-30
|
-2.77
|
|
2019-09-30
|
-3.26
|
|
2018-09-30
|
-2.52
|
|
2017-09-30
|
-3.42
|
|
2016-09-30
|
-0.82
|
|
2015-09-30
|
-0.54
|
|
2014-09-30
|
-5.92
|
|
2013-09-30
|
-7.50
|
|
2011-09-30
|
-7.84
|
|
2010-09-30
|
0.61
|
|
2009-09-30
|
-2.01
|
|
2008-09-30
|
-0.12
|
|
2007-09-30
|
-58.91
|
|
2006-09-30
|
1.62
|
|
2005-09-30
|
7.17
|
|
2004-09-30
|
2.91
|